baber/WOPTO huggingface dataset:
Patent NZ-516375-A (NZ)
Title: Learner directed educational computer system
Inventor: MCGRATH ADRIAN HYLTON
IPC: G09B7/04
Filed: 2001-12-21
Abstract: A method of learner-directed education comprises: storing in computer memory one or more pedagogies representing topics to be mastered by a learner, one or more of the pedagogies including one or more pedagogy items relating to sub-topics of the pedagogy; for one or more of the pedagogy items, storing in computer memory a plurality of instructional approaches to the pedagogy item, the instructional approaches comprising one or more locally stored media items and/or one or more links to remote media items; maintaining in computer memory a learner profile for at least one of the learners; providing the learner with a learning interface to the one or more pedagogies stored in computer memory; displaying to the learner via the learning interface, an indication of learner's mastery of one or more of pedagogical items; updating the learner profile for a learner based on the learner's interaction with the one or more media items and refreshing the indication of the learner's mastery of one or more pedagogical items when the learner profile for that learner is updated. A pedagogy represents a more specific topic for study within a broad subject, which is prescribed for a learner to master to a specified level depending on the class grouping of the student. The pedagogies may be grouped into clusters of related topics referred to as Pedagogy Clusters.
Patent NZ-517303-A (NZ)
Title: Biomedical assay device having and active ingradient electrostatically deposited on a substrate
Inventor: LOEWY ZVI
IPC: A61J3/00
Filed: 2001-03-06
Abstract: An integrated structural unit that includes a diagnostic form that includes at least one active ingredient that is present in an amount that advantageously does not vary by more than about five percent from a predetermined target amount is disclosed, wherein the diagnostic unit form comprises a substrate, a deposit that is disposed on the substrate, and a spreading layer that overlies the deposit and is used to retain and spread a sample of liquid which is to be assayed. The deposit comprises a powder, including the active ingredient(s). The diagnostic form is created via a dry powder deposition apparatus that electrostatically deposits the powder on the substrate utilizing an electrostatic chuck and charged powder delivery apparatus.
Patent NZ-518191-A (NZ)
Title: Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells
Inventor: CIBELLI JOSE
IPC: A61K35/12
Filed: 2000-10-13
Abstract: A method of producing differentiated progenitor cells comprises inducing differentiation of blastocyst-derived morula cells or inner cell mass cells by contacting the cells with at lest on differentiation agent selected form a cytokine, growth factor hormones, extracellular matrix component or an antibody and then isolating the resultant differentiated cells. Transgenic differentiated cells obtained by this method can be used in the in the manufacture of a medicament for cell transplantation therapy preferably to treat a disease or conditions selected from Parkinson's disease, Huntington's disease, Alzheimer's disease, ALS, spinal cord defects to injuries, multiple sclerosis, muscular dystrophy, cystic fibrosis, liver disease, diabetes, heart disease, cartilage defects or injuries, burns, foot ulcers, vascular disease, urinary tract disease, AIDS and cancer. Preferably the differentiated cells are hematopoietic cells or neural cells. Also described is a method for producing a lineage-defective embryonic stem cell.
Patent NZ-521895-A (NZ)
Title: Portable single-hand held diagnostic display unit with a plurality of keys
Inventor: NORMILE JAMES M
IPC: B60S5/00
Filed: 2001-04-24
Abstract: A vehicle diagnostic display unit comprises: a case (100) including a front portion (126), a rear portion (128) , a top portion (130), and a bottom portion (132); a display screen (112) disposed within said front portion; a main support (114) coupled to a side of said case and containing a finger compartment having a depth sufficient for receiving a user's inserted fingers to allow the user to lift the vehicle diagnostic display unit using the inserted fingers and without using the user's thumb; and a plurality of keys disposed on a front surface of said main support; said main support being configured to allow a user to simultaneously lift said diagnostic display unit and access said plurality of keys with a single hand; wherein the finger compartment is disposed on a rear surface of the main support.
Patent NZ-522731-A (NZ)
Title: Beta-carboline derivatives useful as inhibitors of phosphodiesterase
Inventor: SUI ZHIHUA
IPC: C07D471/04
Filed: 2001-05-03
Abstract: beta -carboline derivatives of formula (I), useful as inhibitors of phosphodiesterase in the treatment of sexual dysfunction, including male erectile dysfunction.
Patent NZ-525047-A (NZ)
Title: post, for installing security mesh, with hook type catches and top protector/installation plate
Inventor: COOKSLEY PETER
IPC: E04H17/10
Filed: 2003-03-31
Abstract: The post (or "standard") has hook type "catches" (an upper one upwardly directed and a lower one downwardly directed) and a top protection plate (or "head grip"). The catches serve to attach security mesh fence and the plate serves to allow protection from the upper catch and also allow driving the post into the ground.
Patent NZ-526696-A (NZ)
Title: Essential genes from c.albicans and a method for screening antimycotic substances using said genes
Inventor: LALANNE JEAN-LOUIS
IPC: C12Q1/68
Filed: 1999-09-13
Abstract: A polynucleotide having the sequence as shown in SEQ ID NO:6 and functionally equivalent fragments and proteins encoded by the polynucleotide are described. The polynucleotide is used in methods as a target for screening for antimycotic substances. Also described are diagnostic compositions for fungal infections comprising the polynucleotide, the protein or an antibody directed against the protein. (62) Divided out of 510237
Patent NZ-529284-A (NZ)
Title: Utility usage rate monitor
Inventor: GLADWIN PAUL
IPC: G06Q50/00
Filed: 2002-04-12
Abstract: A utility usage rate monitor that allows a utility consumer to monitor their current rate of consumption of a utility service. The monitor can display the rate of consumption in a form that has particular relevance to the consumer such as the cost or rate of expenditure on the utility or a greenhouse gas emission reduction rate. The monitor has a transducer (1) that senses the rate that the utility is being supplied to the consumer. The transducer produces a signal and sends it to a remotely located consumer interface (15) via a transmission link (16). An awareness of the expenditure or greenhouse gas emission associated with the current levels of consumption of the utility can motivate the consumer to modify their consumption habits and minimise wastage.
Patent NZ-531461-A (NZ)
Title: Expandable gastric retention device
Inventor: AYRES JAMES W
IPC: A61K31/525
Filed: 2001-10-22
Abstract: A gastric retention device comprising a pre-formed gel, with the device formed to a size suitable for administration to a subject is disclosed. The gel may be formed from a polysaccharide. Methods of making the gastric retention device are also disclosed.
Patent NZ-533587-A (NZ)
Title: Immunogenic mimetics of multimer proteins with promiscuous T cell epitope inserts
Inventor: KLYSNER STEEN
IPC: A61K35/76
Filed: 2002-11-15
Abstract: Immunogenic variants of multimeric proteins such as immunogenic variants of interleukin 5 (IL5) and tumour necrosis factor (TNF) alpha are disclosed. The human TNF-alpha analogue can be produced as one single expression product from a cell harbouring an expression vector encoding the analogue, and is described to include: (a) substantial fragments of at least 2 monomeric units of human TNF-alpha, wherein said substantial fragments are joined via peptide bonds through a peptide linker; and (b) at least one MHC Class II binding amino acid sequence that is heterologous to human TNF-alpha. A nucleic acid fragment that encodes an immunogenic analogue is also described. Use of the analogue is disclosed to be for the preparation of a pharmaceutical composition for down-regulating autologous TNF-alpha in a human.
Patent NZ-534742-A (NZ)
Title: Ergonomic controls in a surgical lighting system
Inventor: JESURUN DAVID
IPC: A61B19/00
Filed: 2003-02-05
Abstract: A lighting system with a centrally located handle to allow easy grasping and manipulation of a light source is disclosed. The system includes a light housing 28 with a light source 38 shining through a lens 32 and a handle 36 mounted in the centre of the lens. A bezel 50 is located between the handle and lens and has an actuator associated with it containing controls for adjusting the light intensity. The actuator is designed to be manipulated by the thumb of an operator while grasping the handle. The system has particular application to surgical lighting in operating theatres.
Patent NZ-536260-A (NZ)
Title: Development of a multi-plasmid pol I - pol II based system for the generation of infectious influenza RNA viruses from cloned DNA
Inventor: HOFFMANN ERICH
Filed: 2001-04-27
Abstract: A host cell selected from any of Madin-Darby Canine Kidney (MDCK) cell, VERO cell, CV1 cell, COS-1 cell, COS-7 cell, and BHK-1 cell comprising a composition, comprising a set of plasmids, which generates an infectious influenza virus from cloned viral cDNA, is described. Each plasmid in the set comprises one viral genomic segment, and viral cDNA corresponding to the viral genomic segment is inserted between an RNA polymerase I (poll) promoter and a regulatory element for the synthesis of vRNA or cRNA with an exact 3' end, which results in expression of vRNA or cRNA, which are in turn inserted between an RNA polymerase Il (pol Il promoter and a polyadenylation signal, which results in expression of viral mRNA and a corresponding viral protein. The expression of the full set of vRNAs or cRNAs and viral proteins results in assembly of an infectious influenza virus; Also described is a method for generating a negative strand RNA virus, comprising: (a) mutating one or more viral genomic segments in a plasmid-based system, wherein the plasmid-based system comprises a set of plasmids, wherein each plasmid in the set comprises one viral genomic segment, and wherein viral cDNA corresponding to the viral genomic segment is inserted between an RNA polymerase I (poll) promoter and a regulatory element for the synthesis of vRNA or cRNA with an exact 3' end, which results in expression of vRNA or cRNA, which are in turn inserted between an RNA polymerase I (pol II) promoter and a polyadenylation signal, which results in expression of viral mRNA and a corresponding viral protein, wherein the expression of the full set of vRNAs or cRNAs and viral proteins results in assembly of an infectious influenza virus; (b) introducing the plasmid-based system into a host cell; and (c) culturing the host cell under conditions which permit production of viral proteins and vRNA or cRNA, thereby generating a negative strand RNA virus.
Patent NZ-536420-A (NZ)
Title: Methods of treatment using CTLA-4 antibodies
Inventor: DAVIS THOMAS
IPC: C07K/
Filed: 2003-04-11
Abstract: Use of an effective amount of an anti-CTLA-4 antibody in the manufacture of a medicament for potentiating a memory immune response to an antigen in a human patient wherein the medicament is formulated for the treatment of a patient that has been previously exposed to an immunising dose of the antigen and has developed a primary immune response to the antigen and wherein the effective amount of anti-CTLA-4 antibody is sufficient to enhance a memory immune repose to the antigen in the patient.
Patent NZ-538329-A (NZ)
Title: New process for the synthesis of (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
Inventor: LERESTIF JEAN-MICHEL
IPC: C07D223/16
Filed: 2005-02-18
Abstract: A process for the synthesis of (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane compounds of formula (I) is disclosed, wherein: a compound of formula (III) is reduced to yield a racemic amine of formula (IV), the racemic amine of formula (IV) is resolved by reaction with an optically active diacidic compound (preferably N-acetyl-L-glutamic acid) to yield a compound of formula (VII), the compound of formula (VII) is reacted with a base to yield the corresponding optically active amine of formula (VIII) of configuration (S), the amine of formula (VIII) is reacted with ethyl chloroformate to yield an optically active compound of formula (IX), the carbamate function of the compound of formula (IX) is reduced to yield the compound of formula (I). These compounds of formula (I) are useful as intermediate compounds in the synthesis of ivabradine.
Patent NZ-543328-A (NZ)
Title: A safety device including an attachment extending between a safety belt, safety harness and a fixture
Inventor: TRAVERS IAN
Filed: 2005-10-31
Abstract: A safety device or fall arrest device for attachment to a safety harness. The safety device includes a harness attachment, a support attachment and an elongate restraint extending between the harness attachment and support attachment. The safety device further includes a means for adjusting the length of the elongate restraint. Preferably the elongate restraint is provided with indicia to indicate the distance between the support attachment and the harness attachment as an indication of the maximum distance which workers attached thereto can move from the anchorage point.
Patent NZ-546520-A (NZ)
Title: Fungicidal mixtures for controlling rice pathogens
Inventor: TORMO I BLASCO JORDI
IPC: A01N43/90
Filed: 2004-10-08
Abstract: Disclosed is a fungicidal mixture, which mixture comprises 1) the triazolopyrimidine derivative of the formula I and 2) metalaxyl-M of the formula II, in a synergistically effective amount.
Patent NZ-546688-A (NZ)
Title: Means for disenabling the use of a toilet bowl
Inventor: GREVETT DOUGLAS
IPC: A47K13/24
Filed: 2004-09-23
Abstract: A toilet blocker for temporarily blocking a toilet bowl comprises a cover means (10) for temporarily covering a toilet bowl (50), and a locking arrangement connected to or connectable to the cover means for securing the cover means in position covering the bowl of the toilet. The locking arrangement is arranged to engage with or under the lower edge of the splashback preventer of the rim (54) of the toilet bowl (50). Various embodiments of toilet blocker are disclosed in some of which a bracket (18) rotates into position under the rim 54 of the toilet. In another embodiment the bracket (not shown) is V-shaped and slides and is pulled upwards to lock to the rim (54) of the toilet.
Patent NZ-547004-A (NZ)
Title: Inhaler cap strap
Inventor: BUNCE MARTIN
IPC: A61M15/00
Filed: 2004-11-10
Abstract: An inhaler (1) for dispensing doses of medicament from a container under user activation said inhaling which comprises a body (7) which includes a mouthpiece (5) through which the medicament is dispensed and a cap (2) which can be place in a position to substantially occlude the mouthpiece (5). The cap (2) is attached to said body (7) by a strap (3) which pivots from said body (7), said cap (2) being arranged to slide on the strap (3) such that the cap (2) must translate away from the mouthpiece (5) prior to the pivoting of the strap (3).
Patent NZ-547074-A (NZ)
Title: A catalyst comprising calcined palladium, calcined rhodium, gold and an alkali metal acetate on a support material
Inventor: WANG TAO
IPC: B01J23/46
Filed: 2004-11-19
Abstract: Disclosed is a method of producing alkenyl alkanoates (such as vinyl acetate), comprising: contacting a feed comprising an alkene, an alkanoic acid and an oxidizer to a catalyst or pre-catalyst comprising calcined palladium, calcined rhodium, gold and an alkali metal acetate on a support material. Also disclosed is a method of producing a catalyst or pre-catalyst suitable for assisting in the production of alkenyl alkanoates, comprising: a) contacting palladium, gold and rhodium precursors to a support material; b) calcining the contacted support material in a non-reducing atmosphere; c) reducing the palladium and rhodium precursors by contacting a reducing environment to the support material; and d) contacting an alkali metal acetate to the reduced support material to form an alkenyl alkanoate catalyst or pre-catalyst.
Patent NZ-548189-A (NZ)
Title: Monoparamunity inducers based on attenuated rabbit myxoma viruses
Inventor: MAYR ANTON
IPC: A61K39/00
Filed: 2005-01-21
Abstract: Disclosed is a monoparamunity inducer comprising an attenuated myxomavirus or a component thereof. Also disclosed is a method for producing said monoparamunity inducer.
Patent NZ-549941-A (NZ)
Title: Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
Inventor: MARQUESS DANIEL
IPC: A61K31/46
Filed: 2005-04-06
Abstract: The invention provides novel compounds that possess 5-HT4 receptor agonist activity. Among other properties, compounds of the invention have been found to be potent and selective 5-HT4 receptor agonists. In addition, compounds of the invention have been found to exhibit favorable pharmacokinetic properties which are predictive of good bioavailability upon oral administration.
Patent NZ-550405-A (NZ)
Title: Treatment of diseases
Inventor: YOUL BRYAN
IPC: A61P25/00
Filed: 2005-04-01
Abstract: Provided is the use of a serum composition obtained from a goat after challenge with an immunogen, for the manufacture of a medicament for the treatment of an autoimmune disorder; wherein the immunogen comprises HIV, in intact host cells, cell-free extracts, viral lysate, or a mixture thereof and wherein the autoimmune disorder is selected from the group consisting of lupus, psoriasis, eczema, thyroiditis, scleroderma and polymyotositis.
Patent NZ-550440-A (NZ)
Title: Accessing user interactive electronic communications devices
Inventor: MORRIS TONY
IPC: H04W88/02
Filed: 2005-03-10
Abstract: An accessing system for a user interactive electronic communications device is disclosed. The accessing system comprises a general data interactive zone, accessible via a first user input access protocol, and a secure data interactive zone accessible via a security user input access protocol. The system also includes address register means, where addresses are tagged or otherwise identified to ensure selection and assignment of incoming and/or outgoing data to either the general data interactive zone or the secure data interactive zone.
Patent NZ-551943-A (NZ)
Title: System and method for obtaining pertinent real-time survey evidence
Inventor: SCOTT GRAHAM JOHN
IPC: G06F17/30
Filed: 2005-05-11
Abstract: A system for obtaining pertinent real-time survey evidence comprises a host server; a data acquisition device; and a questions database. The questions database stores at least one survey. Each survey comprises a plurality of questions and associated responses and where each question in the survey has set demographic question criteria. An interviewee is prompted by the data acquisition device to provide a set of demographic data. The data acquisition device is subsequently operable to communicate the set of demographic data to the host server for comparison with the set of demographic data specified for each survey stored in a questions database and, based on the results of the comparison, select a survey for the interviewee to complete. The host server thereafter is operable to communicate a first question and associated responses from the selected survey which is presented to the interviewee by way of the data acquisition device in a manner where each combination of question and response selected by the interviewee is communicated to the host server which then determines the next question and associated responses from the survey, if any, to be presented to the interviewee based on the communicated combination of question and response as well as an assessment of the set of demographic data provided by the interviewee against the set demographic question criteria for each question in the survey. The host server is also operable to store the combination of question and response so provided in a survey record in a response database and associate that record with the selected survey.
Patent NZ-555547-A (NZ)
Title: Defoamers for pulp papermaking applications
Inventor: CHENG HUAI N
IPC: B01D19/04
Filed: 2005-12-08
Abstract: Disclosed is an oil-based composition comprising 6 to 93% of at least one triglyceride oil, 12 to 93% silicone, 0.2 to 12.0% of a silicone-triglyceride stabilising agent, 0.2 to 12.0% of a hydrophobic silica, 0 to 12.0% of one or more surfactants and dispersants, 0 to 10.0% of one or more thickeners, wherein each component has a flash point above 60°C. Further disclosed is a method for using the aforementioned composition in controlling foam in industrial applications such as pulp and paper production.
Patent NZ-556409-A (NZ)
Title: Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
Inventor: MATEO LUIS
IPC: A61K39/12
Filed: 2006-02-17
Abstract: Provided is the use of a poxvirus for the preparation of a vaccine for the rapid induction of a protective immune response within 7 days or less in an animal , including a human, wherein the poxvirus is replication incompetent in said animal, including the human.
Patent NZ-556714-A (NZ)
Title: Nebulizer formulation comprising levalbuterol and ipratroprium
Inventor: MCAFFER IAN GARDNER CAMERON
IPC: A61K31/137
Filed: 2006-01-30
Abstract: Disclosed is the use of a formulation comprising levalbuterol and ipratropium in a pharmaceutically acceptable carrier in the manufacture of a medicament for the treatment of COPD or asthma wherein the medicament is suitable for administration via a nebuliser ampoule containing not more that 2.2ml of said formulation. Also disclosed is a kit comprising:(I) an ampoule, containing a single unit dose of 2.2 ml or less in volume of a therapeutically effective amount of levalbuterol and ipratropium, and a pharmaceutically acceptable carrier; and (2) instructions on how the dose is to be used.
Patent NZ-560648-A (NZ)
Title: Formulation for aviptadil (vasoactive intestinal peptide, VIP)
Inventor: BACHER GERALD
IPC: A61K31/00
Filed: 2006-03-07
Abstract: Disclosed is a long term stable liquid, pharmaceutical formulation comprising 0.001 to 1.0% (w/v) Aviptadil in a buffered formulation excluding a saline formulation and wherein the formulation has a pH of 4.8 to 6.7 at a temperature of approximately 25 degrees Celsius.
Patent NZ-569450-A (NZ)
Title: An isolated protein comprising a cancer-associated variant of Mammalian Scratch
Inventor: CHANAL FRANCINA C
IPC: G01N33/574
Filed: 2006-12-21
Abstract: Disclosed is an isolated protein comprising a cancer-associated variant of Mammalian Scratch, wherein the cancer-associated variant of Mammalian Scratch comprises a transmembrane domain and is expressed on the surface of cancer cells, wherein the protein comprises an amino acid sequence as set forth in SEQ ID NO: 1 or SEQ ID NO:2 or an amino acid sequence having at least 70% identity to SEQ ID NO:1 or SEQ ID NO:2. Also disclosed is the use of the isolated proteins in the manufacture of a medicament to treat or prevent cancer.
Patent NZ-574006-A (NZ)
Title: (s)-(-)-amlodipine camsylate or hydrate thereof and pharmaceutical composition comprising same
Inventor: LEE JAEHEON
IPC: C07D211/90
Filed: 2007-07-16
Abstract: Disclosed is a 3-ethyl-5-methyl-2-(2-aminoethoxy-methyl)-4-(2-chlorophenyl)-6-methyl-l,4-dihydro-3,5-pyridine-dicarboxylate camsylate or a hydrate thereof of formula (I) and formula (II) where n is 1 or 2. Also disclosed is the use of the compounds of formula (I) or (II) as a pharmaceutical composition which can be used in treating cardiovascular diseases.